Break Through Cancer
A collaborative medical research organization
Based in MA
AI Overview
With $60K in lobbying spend across 5 quarterly filings, Break Through Cancer is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2023 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $40K |
| 2024 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Break Through Cancer disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues
Issues relating to coverage and treatment of ovarian cancer.
Issues relating to ovarian cancer research and treatment.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.